KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-06-13

AUTHORS

Barbara Füzi, Rahuman S. Malik-Sheriff, Emma J. Manners, Henning Hermjakob, Gerhard F. Ecker

ABSTRACT

As an alternative to one drug-one target approaches, systems biology methods can provide a deeper insight into the holistic effects of drugs. Network-based approaches are tools of systems biology, that can represent valuable methods for visualizing and analysing drug-protein and protein–protein interactions. In this study, a KNIME workflow is presented which connects drugs to causal target proteins and target proteins to their causal protein interactors. With the collected data, networks can be constructed for visualizing and interpreting the connections. The last part of the workflow provides a topological enrichment test for identifying relevant pathways and processes connected to the submitted data. The workflow is based on openly available databases and their web services. As a case study, compounds of DILIRank were analysed. DILIRank is the benchmark dataset for Drug-Induced Liver Injury by the FDA, where compounds are categorized by their likeliness of causing DILI. The study includes the drugs that are most likely to cause DILI (“mostDILI”) and the ones that are not likely to cause DILI (“noDILI”). After selecting the compounds of interest, down- and upregulated proteins connected to the mostDILI group were identified; furthermore, a liver-specific subset of those was created. The downregulated sub-list had considerably more entries, therefore, network and causal interactome were constructed and topological pathway enrichment analysis was performed with this list. The workflow identified proteins such as Prostaglandin G7H synthase 1 and UDP-glucuronosyltransferase 1A9 as key participants in the potential toxic events disclosing the possible mode of action. The topological network analysis resulted in pathways such as recycling of bile acids and salts and glucuronidation, indicating their involvement in DILI. The KNIME pipeline was built to support target and network-based approaches to analyse any sets of drug data and identify their target proteins, mode of actions and processes they are involved in. The fragments of the pipeline can be used separately or can be combined as required. More... »

PAGES

37

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13321-022-00615-6

DOI

http://dx.doi.org/10.1186/s13321-022-00615-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1148609678

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35692045


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0303", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Macromolecular and Materials Chemistry", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "F\u00fczi", 
        "givenName": "Barbara", 
        "id": "sg:person.011156712555.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011156712555.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.225360.0", 
          "name": [
            "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Malik-Sheriff", 
        "givenName": "Rahuman S.", 
        "id": "sg:person.01253435071.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253435071.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.225360.0", 
          "name": [
            "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manners", 
        "givenName": "Emma J.", 
        "id": "sg:person.011137777617.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011137777617.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK", 
          "id": "http://www.grid.ac/institutes/grid.225360.0", 
          "name": [
            "European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hermjakob", 
        "givenName": "Henning", 
        "id": "sg:person.01070655672.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070655672.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria", 
          "id": "http://www.grid.ac/institutes/grid.10420.37", 
          "name": [
            "Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ecker", 
        "givenName": "Gerhard F.", 
        "id": "sg:person.016071373213.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016071373213.32"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12859-019-3146-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1122307599", 
          "https://doi.org/10.1186/s12859-019-3146-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrg2918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021371713", 
          "https://doi.org/10.1038/nrg2918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1338", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018811977", 
          "https://doi.org/10.1038/nbt1338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41467-021-21056-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1135361689", 
          "https://doi.org/10.1038/s41467-021-21056-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4939-8618-7_16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109831617", 
          "https://doi.org/10.1007/978-1-4939-8618-7_16"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-06-13", 
    "datePublishedReg": "2022-06-13", 
    "description": "As an alternative to one drug-one target approaches, systems biology methods can provide a deeper insight into the holistic effects of drugs. Network-based approaches are tools of systems biology, that can represent valuable methods for visualizing and analysing drug-protein and protein\u2013protein interactions. In this study, a KNIME workflow is presented which connects drugs to causal target proteins and target proteins to their causal protein interactors. With the collected data, networks can be constructed for visualizing and interpreting the connections. The last part of the workflow provides a topological enrichment test for identifying relevant pathways and processes connected to the submitted data. The workflow is based on openly available databases and their web services. As a case study, compounds of DILIRank were analysed. DILIRank is the benchmark dataset for Drug-Induced Liver Injury by the FDA, where compounds are categorized by their likeliness of causing DILI. The study includes the drugs that are most likely to cause DILI (\u201cmostDILI\u201d) and the ones that are not likely to cause DILI (\u201cnoDILI\u201d). After selecting the compounds of interest, down- and upregulated proteins connected to the mostDILI group were identified; furthermore, a liver-specific subset of those was created. The downregulated sub-list had considerably more entries, therefore, network and causal interactome were constructed and topological pathway enrichment analysis was performed with this list. The workflow identified proteins such as Prostaglandin G7H synthase 1 and UDP-glucuronosyltransferase 1A9 as key participants in the potential toxic events disclosing the possible mode of action. The topological network analysis resulted in pathways such as recycling of bile acids and salts and glucuronidation, indicating their involvement in DILI. The KNIME pipeline was built to support target and network-based approaches to analyse any sets of drug data and identify their target proteins, mode of actions and processes they are involved in. The fragments of the pipeline can be used separately or can be combined as required.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13321-022-00615-6", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8558715", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7580445", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.6623097", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4578812", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1042252", 
        "issn": [
          "1758-2946"
        ], 
        "name": "Journal of Cheminformatics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "Drug-Induced Liver Injury", 
      "UDP-glucuronosyltransferase 1A9", 
      "liver injury", 
      "causal drug", 
      "enrichment analysis", 
      "bile acids", 
      "potential toxic events", 
      "pathway enrichment analysis", 
      "toxic events", 
      "drugs", 
      "mode of action", 
      "DILI", 
      "upregulated proteins", 
      "drug data", 
      "target approach", 
      "relevant pathways", 
      "synthase 1", 
      "valuable method", 
      "systems biology methods", 
      "target proteins", 
      "protein", 
      "injury", 
      "pathway", 
      "glucuronidation", 
      "study", 
      "holistic effects", 
      "topological network analysis", 
      "FDA", 
      "biology methods", 
      "possible modes", 
      "action", 
      "involvement", 
      "participants", 
      "group", 
      "key participants", 
      "data", 
      "subset", 
      "more entries", 
      "protein interactors", 
      "target", 
      "database", 
      "analysis", 
      "network-based approach", 
      "available databases", 
      "events", 
      "entry", 
      "test", 
      "protein-protein interactions", 
      "compounds", 
      "effect", 
      "acid", 
      "compounds of interest", 
      "network analysis", 
      "protein interactions", 
      "enrichment tests", 
      "biology", 
      "list", 
      "systems biology", 
      "likeliness", 
      "services", 
      "alternative", 
      "interactome", 
      "method", 
      "approach", 
      "fragments", 
      "interaction", 
      "interactors", 
      "workflow", 
      "part", 
      "tool", 
      "insights", 
      "KNIME workflow", 
      "interest", 
      "process", 
      "deeper insight", 
      "connection", 
      "mode", 
      "one", 
      "salt", 
      "case study", 
      "network", 
      "pipeline", 
      "recycling", 
      "last part", 
      "dataset", 
      "set", 
      "KNIME", 
      "benchmark datasets", 
      "web services"
    ], 
    "name": "KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study", 
    "pagination": "37", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1148609678"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13321-022-00615-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35692045"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13321-022-00615-6", 
      "https://app.dimensions.ai/details/publication/pub.1148609678"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_949.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13321-022-00615-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13321-022-00615-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13321-022-00615-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13321-022-00615-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13321-022-00615-6'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      119 URIs      106 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13321-022-00615-6 schema:about anzsrc-for:03
2 anzsrc-for:0303
3 schema:author Ne20d08fa1eb84804a95b2a065ee6ce24
4 schema:citation sg:pub.10.1007/978-1-4939-8618-7_16
5 sg:pub.10.1038/nbt1338
6 sg:pub.10.1038/nrg2918
7 sg:pub.10.1038/s41467-021-21056-z
8 sg:pub.10.1186/s12859-019-3146-1
9 schema:datePublished 2022-06-13
10 schema:datePublishedReg 2022-06-13
11 schema:description As an alternative to one drug-one target approaches, systems biology methods can provide a deeper insight into the holistic effects of drugs. Network-based approaches are tools of systems biology, that can represent valuable methods for visualizing and analysing drug-protein and protein–protein interactions. In this study, a KNIME workflow is presented which connects drugs to causal target proteins and target proteins to their causal protein interactors. With the collected data, networks can be constructed for visualizing and interpreting the connections. The last part of the workflow provides a topological enrichment test for identifying relevant pathways and processes connected to the submitted data. The workflow is based on openly available databases and their web services. As a case study, compounds of DILIRank were analysed. DILIRank is the benchmark dataset for Drug-Induced Liver Injury by the FDA, where compounds are categorized by their likeliness of causing DILI. The study includes the drugs that are most likely to cause DILI (“mostDILI”) and the ones that are not likely to cause DILI (“noDILI”). After selecting the compounds of interest, down- and upregulated proteins connected to the mostDILI group were identified; furthermore, a liver-specific subset of those was created. The downregulated sub-list had considerably more entries, therefore, network and causal interactome were constructed and topological pathway enrichment analysis was performed with this list. The workflow identified proteins such as Prostaglandin G7H synthase 1 and UDP-glucuronosyltransferase 1A9 as key participants in the potential toxic events disclosing the possible mode of action. The topological network analysis resulted in pathways such as recycling of bile acids and salts and glucuronidation, indicating their involvement in DILI. The KNIME pipeline was built to support target and network-based approaches to analyse any sets of drug data and identify their target proteins, mode of actions and processes they are involved in. The fragments of the pipeline can be used separately or can be combined as required.
12 schema:genre article
13 schema:isAccessibleForFree true
14 schema:isPartOf Na20ef549fdc24959a236d82193dc3f45
15 Nf9935fde0c9448c68758d85a308ab21c
16 sg:journal.1042252
17 schema:keywords DILI
18 Drug-Induced Liver Injury
19 FDA
20 KNIME
21 KNIME workflow
22 UDP-glucuronosyltransferase 1A9
23 acid
24 action
25 alternative
26 analysis
27 approach
28 available databases
29 benchmark datasets
30 bile acids
31 biology
32 biology methods
33 case study
34 causal drug
35 compounds
36 compounds of interest
37 connection
38 data
39 database
40 dataset
41 deeper insight
42 drug data
43 drugs
44 effect
45 enrichment analysis
46 enrichment tests
47 entry
48 events
49 fragments
50 glucuronidation
51 group
52 holistic effects
53 injury
54 insights
55 interaction
56 interactome
57 interactors
58 interest
59 involvement
60 key participants
61 last part
62 likeliness
63 list
64 liver injury
65 method
66 mode
67 mode of action
68 more entries
69 network
70 network analysis
71 network-based approach
72 one
73 part
74 participants
75 pathway
76 pathway enrichment analysis
77 pipeline
78 possible modes
79 potential toxic events
80 process
81 protein
82 protein interactions
83 protein interactors
84 protein-protein interactions
85 recycling
86 relevant pathways
87 salt
88 services
89 set
90 study
91 subset
92 synthase 1
93 systems biology
94 systems biology methods
95 target
96 target approach
97 target proteins
98 test
99 tool
100 topological network analysis
101 toxic events
102 upregulated proteins
103 valuable method
104 web services
105 workflow
106 schema:name KNIME workflow for retrieving causal drug and protein interactions, building networks, and performing topological enrichment analysis demonstrated by a DILI case study
107 schema:pagination 37
108 schema:productId N0c1298c061324cb3b504f546355e4daa
109 N104340244da347349f8bfad9b8faa33a
110 Ndcf4295eb9e0415ca0fb57d926ae458a
111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148609678
112 https://doi.org/10.1186/s13321-022-00615-6
113 schema:sdDatePublished 2022-11-24T21:09
114 schema:sdLicense https://scigraph.springernature.com/explorer/license/
115 schema:sdPublisher N3b3afe237e0e4bba9459a5e79916f601
116 schema:url https://doi.org/10.1186/s13321-022-00615-6
117 sgo:license sg:explorer/license/
118 sgo:sdDataset articles
119 rdf:type schema:ScholarlyArticle
120 N0c1298c061324cb3b504f546355e4daa schema:name pubmed_id
121 schema:value 35692045
122 rdf:type schema:PropertyValue
123 N104340244da347349f8bfad9b8faa33a schema:name dimensions_id
124 schema:value pub.1148609678
125 rdf:type schema:PropertyValue
126 N3211354262e54deda06a92142ce5ce4a rdf:first sg:person.016071373213.32
127 rdf:rest rdf:nil
128 N3b3afe237e0e4bba9459a5e79916f601 schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 Na20ef549fdc24959a236d82193dc3f45 schema:issueNumber 1
131 rdf:type schema:PublicationIssue
132 Nb77a7bc15bfe4bb2a4f1cc9a78dd2b39 rdf:first sg:person.01253435071.76
133 rdf:rest Nf7d1459b2e524feba0781a736154eae4
134 Nbd44b986ca78493aa8cc9e8785d9f271 rdf:first sg:person.01070655672.90
135 rdf:rest N3211354262e54deda06a92142ce5ce4a
136 Ndcf4295eb9e0415ca0fb57d926ae458a schema:name doi
137 schema:value 10.1186/s13321-022-00615-6
138 rdf:type schema:PropertyValue
139 Ne20d08fa1eb84804a95b2a065ee6ce24 rdf:first sg:person.011156712555.93
140 rdf:rest Nb77a7bc15bfe4bb2a4f1cc9a78dd2b39
141 Nf7d1459b2e524feba0781a736154eae4 rdf:first sg:person.011137777617.54
142 rdf:rest Nbd44b986ca78493aa8cc9e8785d9f271
143 Nf9935fde0c9448c68758d85a308ab21c schema:volumeNumber 14
144 rdf:type schema:PublicationVolume
145 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
146 schema:name Chemical Sciences
147 rdf:type schema:DefinedTerm
148 anzsrc-for:0303 schema:inDefinedTermSet anzsrc-for:
149 schema:name Macromolecular and Materials Chemistry
150 rdf:type schema:DefinedTerm
151 sg:grant.4578812 http://pending.schema.org/fundedItem sg:pub.10.1186/s13321-022-00615-6
152 rdf:type schema:MonetaryGrant
153 sg:grant.6623097 http://pending.schema.org/fundedItem sg:pub.10.1186/s13321-022-00615-6
154 rdf:type schema:MonetaryGrant
155 sg:grant.7580445 http://pending.schema.org/fundedItem sg:pub.10.1186/s13321-022-00615-6
156 rdf:type schema:MonetaryGrant
157 sg:grant.8558715 http://pending.schema.org/fundedItem sg:pub.10.1186/s13321-022-00615-6
158 rdf:type schema:MonetaryGrant
159 sg:journal.1042252 schema:issn 1758-2946
160 schema:name Journal of Cheminformatics
161 schema:publisher Springer Nature
162 rdf:type schema:Periodical
163 sg:person.01070655672.90 schema:affiliation grid-institutes:grid.225360.0
164 schema:familyName Hermjakob
165 schema:givenName Henning
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070655672.90
167 rdf:type schema:Person
168 sg:person.011137777617.54 schema:affiliation grid-institutes:grid.225360.0
169 schema:familyName Manners
170 schema:givenName Emma J.
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011137777617.54
172 rdf:type schema:Person
173 sg:person.011156712555.93 schema:affiliation grid-institutes:grid.10420.37
174 schema:familyName Füzi
175 schema:givenName Barbara
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011156712555.93
177 rdf:type schema:Person
178 sg:person.01253435071.76 schema:affiliation grid-institutes:grid.225360.0
179 schema:familyName Malik-Sheriff
180 schema:givenName Rahuman S.
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253435071.76
182 rdf:type schema:Person
183 sg:person.016071373213.32 schema:affiliation grid-institutes:grid.10420.37
184 schema:familyName Ecker
185 schema:givenName Gerhard F.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016071373213.32
187 rdf:type schema:Person
188 sg:pub.10.1007/978-1-4939-8618-7_16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109831617
189 https://doi.org/10.1007/978-1-4939-8618-7_16
190 rdf:type schema:CreativeWork
191 sg:pub.10.1038/nbt1338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018811977
192 https://doi.org/10.1038/nbt1338
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/nrg2918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021371713
195 https://doi.org/10.1038/nrg2918
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/s41467-021-21056-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1135361689
198 https://doi.org/10.1038/s41467-021-21056-z
199 rdf:type schema:CreativeWork
200 sg:pub.10.1186/s12859-019-3146-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1122307599
201 https://doi.org/10.1186/s12859-019-3146-1
202 rdf:type schema:CreativeWork
203 grid-institutes:grid.10420.37 schema:alternateName Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria
204 schema:name Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria
205 rdf:type schema:Organization
206 grid-institutes:grid.225360.0 schema:alternateName European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK
207 schema:name European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, UK
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...